ERBB2 and neoplasm: An integrated approach considering the animal’s genetic background articulated with histological features, tissular and serum HER2 expression, as well as with molecular characteristics of the neoplasms (namely gene and/or protein expression quantification) will allow the development of management strategies tailored to the specificities of the animal and of the tumoral lesion.